Gstp1 (glutathione S-transferase, pi 1) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Gstp1 (glutathione S-transferase, pi 1) Mus musculus
Analyze
Symbol: Gstp1
Name: glutathione S-transferase, pi 1
RGD ID: 1620115
MGI Page MGI
Description: Enables JUN kinase binding activity; glutathione transferase activity; and kinase regulator activity. Involved in several processes, including negative regulation of cell population proliferation; negative regulation of cytokine production; and negative regulation of intracellular signal transduction. Acts upstream of or within glutathione metabolic process. Located in cytosol. Part of protein-containing complex. Is expressed in several structures, including alimentary system; central nervous system; genitourinary system; respiratory system; and sensory organ. Human ortholog(s) of this gene implicated in several diseases, including allergic disease (multiple); carcinoma (multiple); hematologic cancer (multiple); reproductive organ cancer (multiple); and respiratory system disease (multiple). Orthologous to human GSTP1 (glutathione S-transferase pi 1).
Type: protein-coding
RefSeq Status: VALIDATED
Previously known as: glutathione S-transferase P 1; Gst; GST class-pi; Gst p-1; gst P1; GST YF-YF; GST-piB; GstpiB; preadipocyte growth factor
RGD Orthologs
Human
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Alliance Orthologs
More Info more info ...
Related Pseudogenes: Gm3266  
Latest Assembly: GRCm39 - Mouse Genome Assembly GRCm39
Position:
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39194,085,411 - 4,087,912 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl194,085,407 - 4,087,985 (-)EnsemblGRCm39 Ensembl
GRCm38194,035,411 - 4,037,912 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl194,035,407 - 4,037,985 (-)EnsemblGRCm38mm10GRCm38
MGSCv37194,035,411 - 4,037,912 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36194,035,411 - 4,037,912 (-)NCBIMGSCv36mm8
Celera193,906,327 - 3,908,828 (-)NCBICelera
Cytogenetic Map19ANCBI
cM Map193.75NCBI
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
Acute Coronary Syndrome  (ISO)
acute kidney failure  (ISO)
acute lymphoblastic leukemia  (ISO)
acute myeloid leukemia  (ISO)
Aicardi-Goutieres Syndrome 3  (ISO)
Airway Obstruction  (ISO)
alcohol use disorder  (ISO)
allergic disease  (ISO)
Alzheimer's disease  (IEP,ISO)
amphetamine abuse  (ISO)
amyotrophic lateral sclerosis  (ISO)
asthma  (IAGP,ISO)
atopic dermatitis  (ISO)
autism spectrum disorder  (ISO)
autistic disorder  (ISO)
bone marrow disease  (ISO)
breast cancer  (ISO)
Breast Neoplasms  (ISO)
bronchiolo-alveolar adenocarcinoma  (ISO)
bronchopulmonary dysplasia  (ISO)
bronchus carcinoma  (ISO)
carcinoma  (ISO)
carotid artery disease  (ISO)
Chemical and Drug Induced Liver Injury  (ISO)
Chemotherapy-Induced Febrile Neutropenia  (ISO)
cholangiocarcinoma  (ISO)
Cholangiofibrosis  (ISO)
cholestasis  (ISO)
Chromosome Aberrations  (ISO)
Chronic Cerebral Hypoperfusion  (ISO)
chronic myeloid leukemia  (ISO)
chronic obstructive pulmonary disease  (ISO)
clear cell renal cell carcinoma  (ISO)
cocaine dependence  (ISO)
colorectal adenoma  (ISO)
congenital heart disease  (ISO)
conjunctivochalasis  (ISO)
contact dermatitis  (ISO)
Cough  (ISO)
cystic fibrosis  (ISO)
diffuse large B-cell lymphoma  (ISO)
Disease Progression  (ISO)
drug allergy  (ISO)
Drug-Induced Leukopenia  (ISO)
Drug-induced Neutropenia  (ISO)
esophagus squamous cell carcinoma  (ISO)
essential tremor  (ISO)
Experimental Liver Neoplasms  (ISO)
Experimental Seizures  (ISO)
Focal Nodular Hyperplasia  (ISO)
Gallbladder Neoplasms  (ISO)
Graves' disease  (ISO)
hematopoietic system disease  (ISO)
hepatocellular carcinoma  (ISO)
high grade glioma  (ISO)
Hodgkin's lymphoma  (ISO)
hypertension  (ISO)
immune system disease  (ISO)
immunodeficiency 90  (ISO)
intellectual disability  (ISO)
Kidney Calculi  (ISO)
kidney disease  (ISO)
Kuhnt-Junius degeneration  (ISO)
Laryngeal Neoplasms  (ISO)
late onset Parkinson's disease  (ISO)
liver disease  (ISO)
lung disease  (ISO)
Lung Neoplasms  (ISO)
lung non-small cell carcinoma  (ISO)
lymphoid leukemia  (ISO)
malignant astrocytoma  (ISO)
melanoma  (ISO)
meningitis  (ISO)
metabolic dysfunction-associated steatotic liver disease  (ISO)
mitochondrial metabolism disease  (ISO)
movement disease  (ISO)
multiple myeloma  (ISO)
multiple sclerosis  (ISO)
myelodysplastic syndrome  (ISO)
myeloid leukemia  (ISO)
Myocardial Ischemia  (ISO)
Necrosis  (ISO)
oral squamous cell carcinoma  (ISO)
osteoporosis  (ISO)
osteosarcoma  (ISO)
ovarian cancer  (ISO)
pancreatic cancer  (ISO)
pancreatic ductal carcinoma  (ISO)
Parkinson's disease  (ISO)
Perennial Allergic Rhinitis  (ISO)
peripheral nervous system disease  (ISO)
peritonitis  (ISO)
Plasmodium falciparum malaria  (ISO)
pre-eclampsia  (ISO)
pre-malignant neoplasm  (ISO)
prostate cancer  (ISO)
prostate carcinoma in situ  (ISO)
prostatic hypertrophy  (ISO)
Prostatic Neoplasms  (ISO)
Pseudomonas Infections  (ISO)
psoriasis  (ISO)
pulmonary emphysema  (ISO)
pulmonary fibrosis  (ISO)
renal cell carcinoma  (ISO)
Reperfusion Injury  (IEP)
Respiratory Sounds  (ISO)
respiratory system disease  (ISO)
sarcoma  (ISO)
senile cataract  (ISO)
squamous cell carcinoma  (ISO)
Stomach Neoplasms  (ISO)
substance-induced psychosis  (ISO)
testicular cancer  (ISO)
toxic encephalopathy  (ISO)
type 2 diabetes mellitus  (ISO)
Ureteral Calculi  (ISO)
urinary bladder cancer  (ISO)
vestibular disease  (ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-artemisinin  (ISO)
(-)-epigallocatechin 3-gallate  (ISO)
(3,4-dihydroxyphenyl)acetic acid  (ISO)
(E)-4-hydroxynon-2-enal  (ISO)
(R)-lipoic acid  (ISO)
(RS)-goitrin  (ISO)
1,2-Dibromo-3-chloropropane  (ISO)
1,2-dichlorobenzene  (ISO)
1,2-dichloroethane  (EXP)
1,2-dimethylhydrazine  (EXP)
1,3-dichloropropan-2-ol  (ISO)
1,3-dinitrobenzene  (ISO)
1,4-dioxane  (EXP)
1,4-phenylenediamine  (ISO)
1-\{2-[(4-chlorobenzyl)sulfanyl]-2-(2,4-dichlorophenyl)ethyl\}-1H-imidazole  (ISO)
1-bromopropane  (ISO)
1-chloro-2,4-dinitrobenzene  (ISO)
1-Hydroxypyrene  (ISO)
1-naphthyl isothiocyanate  (EXP,ISO)
15-deoxy-Delta(12,14)-prostaglandin J2  (ISO)
17beta-estradiol  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (EXP)
2,2',5,5'-tetrachlorobiphenyl  (ISO)
2,2,2-tetramine  (ISO)
2,3',4,4',5-Pentachlorobiphenyl  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3,7,8-Tetrachlorodibenzofuran  (EXP,ISO)
2,4,6-trinitrotoluene  (ISO)
2,4-dibromophenyl 2,4,5-tribromophenyl ether  (EXP,ISO)
2,5-di-tert-butylbenzene-1,4-diol  (ISO)
2,5-hexanedione  (ISO)
2,6-di-tert-butyl-4-methylphenol  (EXP,ISO)
2,6-dimethoxyphenol  (ISO)
2-acetamidofluorene  (ISO)
2-Acetoxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine  (ISO)
2-allylphenol  (ISO)
2-amino-4,6-dinitrotoluene  (ISO)
2-amino-7-methyl-1,7-dihydro-6H-purin-6-one  (ISO)
2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one  (ISO)
2-hexenal  (ISO)
2-hydroxybenzoic acid (3,3,5-trimethylcyclohexyl) ester  (ISO)
2-methoxyethanol  (ISO)
2-nitrofluorene  (ISO)
2-phenylpropanal  (ISO)
2-tert-butylhydroquinone  (ISO)
3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine  (ISO)
3,3',4,4',5-pentachlorobiphenyl  (ISO)
3,3',5-triiodo-L-thyronine  (ISO)
3,4-methylenedioxymethamphetamine  (ISO)
3-chloropropane-1,2-diol  (ISO)
3-methylcholanthrene  (ISO)
3-nitropropanoic acid  (ISO)
3-phenoxybenzoic acid  (ISO)
3-phenylprop-2-enal  (ISO)
3H-1,2-dithiole-3-thione  (ISO)
4'-hydroxydiclofenac  (ISO)
4,4'-sulfonyldiphenol  (EXP,ISO)
4-amino-2,6-dinitrotoluene  (ISO)
4-Chloronitrobenzene  (ISO)
4-hydroxynon-2-enal  (EXP,ISO)
4-Propylphenol  (ISO)
4-vinylcyclohexene dioxide  (ISO)
5-aza-2'-deoxycytidine  (EXP,ISO)
5-fluorouracil  (ISO)
5-hydroxydiclofenac  (ISO)
5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole  (ISO)
7,12-dimethyltetraphene  (ISO)
acetamide  (ISO)
acetic acid  (ISO)
aclacinomycin A  (ISO)
acridine orange  (ISO)
acridine orange free base  (ISO)
acrolein  (EXP,ISO)
acrylamide  (ISO)
actinomycin D  (ISO)
aflatoxin B1  (ISO)
aflatoxin B1 exo-8,9-epoxide  (ISO)
aldehydo-D-glucose  (ISO)
aldosterone  (ISO)
all-trans-retinoic acid  (ISO)
all-trans-retinol  (ISO)
allyl isothiocyanate  (ISO)
alpha-hexachlorocyclohexane  (ISO)
alpha-methyl-L-dopa  (ISO)
alpha-naphthoflavone  (ISO)
amitriptyline  (ISO)
ammonium chloride  (ISO)
amphotericin B  (ISO)
angelica lactone  (EXP)
anthracene-1,8,9-triol  (ISO)
aristolochic acid A  (ISO)
arotinoid acid  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenite(3-)  (EXP,ISO)
arsenous acid  (ISO)
artesunate  (ISO)
asbestos  (ISO)
atovaquone  (ISO)
ATP  (ISO)
atrazine  (EXP,ISO)
Aurothioglucose  (ISO)
avobenzone  (ISO)
Bardoxolone methyl  (ISO)
benzene  (ISO)
benzo[a]pyrene  (EXP,ISO)
benzo[a]pyrene diol epoxide I  (ISO)
benzo[c]phenanthrene  (ISO)
BENZO[G]CHRYSENE  (ISO)
Benzo[k]fluoranthene  (EXP)
benzopyran  (ISO)
benzyl isothiocyanate  (ISO)
beta-lapachone  (ISO)
beta-naphthoflavone  (ISO)
betamethasone dipropionate  (ISO)
bifenthrin  (EXP)
bilirubin IXalpha  (ISO)
bis(2-ethylhexyl) phthalate  (EXP,ISO)
bisphenol A  (ISO)
bisphenol AF  (ISO)
Bisphenol B  (ISO)
bromindione  (ISO)
Bucillamine  (ISO)
bufalin  (ISO)
buspirone  (ISO)
busulfan  (ISO)
buta-1,3-diene  (EXP)
butylated hydroxyanisole  (EXP,ISO)
butyric acid  (ISO)
cadmium atom  (ISO)
cadmium dichloride  (EXP,ISO)
cafestol  (ISO)
camptothecin  (ISO)
cannabidiol  (ISO)
capsaicin  (ISO)
captafol  (ISO)
captan  (EXP,ISO)
carbamazepine-10,11-epoxide  (ISO)
carbon nanotube  (EXP,ISO)
carboplatin  (ISO)
carmustine  (ISO)
carnosic acid  (ISO)
cefaloridine  (ISO)
celecoxib  (ISO)
cerium trichloride  (ISO)
CHIR 99021  (ISO)
chlorambucil  (ISO)
chloramphenicol palmitate  (ISO)
chlorobenzene  (ISO)
chloroethene  (ISO)
chloropicrin  (ISO)
chlorotrianisene  (ISO)
chlortetracycline  (ISO)
chromium(6+)  (EXP)
cimetidine  (ISO)
cis-caffeic acid  (ISO)
cisplatin  (ISO)
Clasto-Lactacystin beta-lactone  (ISO)
clobetasol  (EXP)
clofazimine  (ISO)
clofibrate  (EXP,ISO)
clomipramine  (ISO)
clotrimazole  (ISO)
clozapine  (ISO)
cobamamide  (ISO)
cocaine  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
cortisol  (ISO)
coumarin  (EXP,ISO)
crocidolite asbestos  (ISO)
crotonaldehyde  (ISO)
crystal violet  (ISO)
cumene  (ISO)
cumene hydroperoxide  (ISO)
curcumin  (ISO)
cyclohexanols  (ISO)
cyclophosphamide  (EXP,ISO)
cycloprothrin  (ISO)
cypermethrin  (ISO)
D-glucose  (ISO)
dapsone  (EXP)
decabromodiphenyl ether  (ISO)
deoxycholic acid  (ISO)
dexamethasone  (ISO)
Diallyl sulfide  (ISO)
diallyl trisulfide  (ISO)
diarsenic trioxide  (ISO)
dibenz[a,h]anthracene  (EXP)
dibenzo[a,l]pyrene  (ISO)
dibenzofurans  (EXP)
dibutyl phthalate  (ISO)
diclofenac  (ISO)
dienestrol  (ISO)
diethyl maleate  (ISO)
diethyldithiocarbamic acid  (ISO)
diethylstilbestrol  (ISO)
dihydrolipoic acid  (ISO)
dimethyl sulfoxide  (ISO)
dimethylarsinic acid  (EXP,ISO)
dinophysistoxin 1  (ISO)
dioxygen  (ISO)
diquat  (EXP)
disodium selenite  (ISO)
diuron  (ISO)
dopamine  (ISO)
dorsomorphin  (ISO)
doxepin  (ISO)
doxorubicin  (EXP,ISO)
doxycycline  (ISO)
ebselen  (ISO)
econazole  (ISO)
elemental selenium  (ISO)
emodin  (ISO)
endosulfan  (ISO)
enoxacin  (ISO)
enzyme inhibitor  (ISO)
epoxiconazole  (EXP,ISO)
equilin  (ISO)
ergotamine  (ISO)
eriodictyol  (ISO)
erythrosin B  (ISO)
Estradiol 17beta-cyclopentylpropionate  (ISO)
etacrynic acid  (ISO)
ethanol  (EXP,ISO)
ethoxyquin  (ISO)
ethylbenzene  (ISO)
etoposide  (ISO)
eugenol  (ISO)
fenbendazole  (ISO)
fenofibrate  (ISO)
fenvalerate  (ISO)
ferric oxide  (ISO)
fipronil  (ISO)
flavonoids  (ISO)
flufenamic acid  (ISO)
flunarizine  (ISO)
Fluocinonide  (ISO)
flurotyl  (ISO)
flutamide  (ISO)
flutriafol  (ISO)
folic acid  (EXP,ISO)
folpet  (EXP)
formaldehyde  (ISO)
FR900359  (ISO)
fumaraldehyde  (ISO)
fumonisin B1  (EXP)
furan  (ISO)
furfural  (ISO)
galangin  (ISO)
gamma-glutamyl-glutathione  (ISO)
genistein  (EXP)
gentamycin  (ISO)
geraniol  (ISO)
glucose  (ISO)
glutathione  (EXP,ISO)
glycerol  (ISO)
haloperidol  (ISO)
hemin  (ISO)
heptan-2-one  (ISO)
herbicide  (ISO)
hexachlorobenzene  (ISO)
hexachlorophene  (ISO)
homocysteine  (ISO)
hydralazine  (ISO)
hydrogen peroxide  (EXP,ISO)
hydroquinone  (ISO)
hydroxyzine  (ISO)
hypericin  (ISO)
ifosfamide  (ISO)
imipramine  (ISO)
indirubin  (ISO)
indole-3-methanol  (EXP,ISO)
iodide salt  (ISO)
iodoquinol  (ISO)
iron dichloride  (ISO)
isomethyleugenol  (ISO)
isoniazide  (ISO)
isopimpinellin  (EXP)
isothiocyanate  (ISO)
isotretinoin  (ISO)
itraconazole  (ISO)
ivermectin  (ISO)
kaempferol  (ISO)
kahweol  (ISO)
ketoconazole  (ISO)
L-ascorbic acid  (ISO)
L-cysteine  (EXP)
L-selenocysteine  (ISO)
lansoprazole  (ISO)
lead diacetate  (EXP,ISO)
lead(0)  (ISO)
leflunomide  (ISO)
lipoic acid  (ISO)
lipopolysaccharide  (EXP,ISO)
lithium atom  (ISO)
lithium hydride  (ISO)
LY294002  (ISO)
lycopene  (ISO)
malathion  (ISO)
maneb  (EXP)
manganese atom  (ISO)
manganese(0)  (ISO)
mebendazole  (ISO)
Meclizine  (ISO)
mefenamic acid  (ISO)
MeIQx  (ISO)
melatonin  (EXP,ISO)
melphalan  (ISO)
merbromin  (ISO)
mercury atom  (ISO)
mercury dibromide  (ISO)
mercury dichloride  (ISO)
mercury(0)  (ISO)
Mesna  (EXP)
metformin  (ISO)
methamphetamine  (ISO)
methapyrilene  (ISO)
methidathion  (EXP)
methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate  (ISO)
methylarsonic acid  (ISO)
methylene blue  (ISO)
methylmercury chloride  (ISO)
microcystin  (ISO)
microcystin RR  (ISO)
microcystin-LR  (ISO)
minocycline  (ISO)
mitomycin C  (ISO)
Mitotane  (ISO)
MK 571  (ISO)
monobromobimane  (ISO)
monocrotophos  (ISO)
monosodium L-glutamate  (EXP)
Muraglitazar  (ISO)
N,N-diethyl-m-toluamide  (ISO)
N-acetyl-1,4-benzoquinone imine  (ISO)
N-acetyl-L-cysteine  (ISO)
N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal  (ISO)
N-hydroxy-PhIP  (ISO)
N-methyl-N'-nitro-N-nitrosoguanidine  (EXP)
N-nitrosodiethylamine  (EXP,ISO)
N-nitrosomorpholine  (ISO)
naphthalene  (EXP)
naringin  (ISO)
nefazodone  (ISO)
nevirapine  (ISO)
nicotinamide  (ISO)
nifedipine  (ISO)
nimesulide  (ISO)
nisoldipine  (ISO)
nitrendipine  (ISO)
nitrogen dioxide  (ISO)
Nutlin-3  (ISO)
O-acetyl-L-carnitine  (ISO)
O-methyleugenol  (ISO)
obeticholic acid  (ISO)
ochratoxin A  (ISO)
okadaic acid  (EXP,ISO)
oltipraz  (EXP,ISO)
omeprazole  (ISO)
orphenadrine  (ISO)
oxaliplatin  (ISO)
oxiconazole  (ISO)
oxidopamine  (ISO)
oxybenzone  (ISO)
oxyphenbutazone  (ISO)
ozone  (ISO)
p-toluidine  (ISO)
paclitaxel  (ISO)
paracetamol  (EXP,ISO)
paraquat  (EXP,ISO)
pararosaniline free base  (ISO)
parathion  (EXP,ISO)
pentachlorobenzene  (ISO)
perfluorohexanesulfonic acid  (EXP)
perfluorooctane-1-sulfonic acid  (EXP,ISO)
perfluorooctanoic acid  (EXP,ISO)
permethrin  (ISO)
phenethyl caffeate  (ISO)
phenethyl isothiocyanate  (ISO)
phenobarbital  (ISO)
phenolphthalein  (ISO)
Phenoxybenzamine  (ISO)
phenylbutazone  (ISO)
phenylmercury acetate  (ISO)
PhIP  (EXP,ISO)
phlorizin  (EXP)
phorbol 13-acetate 12-myristate  (EXP,ISO)
phosphoramide mustard  (ISO)
phylloquinone  (ISO)
pioglitazone  (ISO)
piperonyl butoxide  (ISO)
pirinixic acid  (EXP)
platinum  (ISO)
platinum(0)  (ISO)
plumbagin  (ISO)
potassium chromate  (EXP)
potassium dichromate  (EXP)
PRIM-O-GLUCOSYLCIMIFUGIN  (ISO)
propane-1,2-diol  (ISO)
Propiverine  (ISO)
Pyrantel pamoate  (ISO)
pyrazinecarboxamide  (ISO)
Pyridostigmine bromide  (ISO)
pyrimethamine  (ISO)
pyrimidifen  (ISO)
quercetin  (EXP,ISO)
quercitrin  (ISO)
quinidine  (ISO)
quinine  (ISO)
resveratrol  (EXP,ISO)
rifampicin  (ISO)
rotenone  (ISO)
S-butyl-DL-homocysteine (S,R)-sulfoximine  (ISO)
S-hexylglutathione  (ISO)
salvianolic acid B  (EXP)
sanguinarine  (EXP,ISO)
SB 203580  (ISO)
SB 431542  (ISO)
selenium atom  (ISO)
selenomethionine  (ISO)
silicon dioxide  (ISO)
silver atom  (EXP)
silver(0)  (EXP)
simvastatin  (ISO)
sodium arsenite  (EXP,ISO)
sodium chloride  (ISO)
sodium dichromate  (EXP)
soybean oil  (ISO)
stavudine  (ISO)
stilbene oxide  (ISO)
streptozocin  (ISO)
styrene  (ISO)
styrene oxide  (ISO)
Sudan I  (ISO)
sulconazole  (ISO)
sulfamethoxazole  (ISO)
sulfaphenazole  (ISO)
sulfasalazine  (ISO)
sulfinpyrazone  (ISO)
sulforaphane  (EXP,ISO)
sulfotep  (ISO)
sulfur dioxide  (ISO)
sulindac sulfide  (ISO)
sulindac sulfone  (ISO)
T-2 toxin  (ISO)
tamoxifen  (EXP,ISO)
Tanshinone I  (ISO)
tauroursodeoxycholic acid  (ISO)
temephos  (ISO)
temozolomide  (ISO)
teniposide  (ISO)
terbinafine  (ISO)
tert-butyl hydroperoxide  (EXP)
Tesaglitazar  (ISO)
Testosterone propionate  (ISO)
tetrachloromethane  (EXP,ISO)
tetracycline  (ISO)
thiabendazole  (ISO)
thioacetamide  (ISO)
thiophenes  (ISO)
thiostrepton  (ISO)
Thiotepa  (ISO)
Thonningianin A  (ISO)
thymoquinone  (ISO)
Tiopronin  (ISO)
titanium dioxide  (ISO)
tolnaftate  (ISO)
toluene  (ISO)
toluene 2,4-diisocyanate  (ISO)
tranilast  (ISO)
trans-caffeic acid  (ISO)
trichloroethene  (ISO)
trichostatin A  (EXP,ISO)
trimethylarsine oxide  (ISO)
triphenyl phosphate  (ISO)
Tris(1-aziridinyl)phosphine oxide  (ISO)
Tris(2,3-dibromopropyl) phosphate  (ISO)
troglitazone  (ISO)
uranium atom  (ISO)
valproic acid  (EXP,ISO)
vincaleukoblastine  (ISO)
vinclozolin  (ISO)
vincristine  (ISO)
vitamin D  (EXP)
vitamin E  (ISO)
vorinostat  (ISO)
WR-1065  (ISO)
xanthohumol  (ISO)
XAV939  (ISO)
zearalenone  (EXP)
zerumbone  (EXP)
zinc dichloride  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
animal organ regeneration  (ISO,ISS)
cellular response to cell-matrix adhesion  (ISO,ISS)
cellular response to epidermal growth factor stimulus  (ISO,ISS)
cellular response to glucocorticoid stimulus  (ISO,ISS)
cellular response to insulin stimulus  (ISO,ISS)
cellular response to lipopolysaccharide  (IDA)
common myeloid progenitor cell proliferation  (IMP)
glutathione derivative biosynthetic process  (ISO,ISS)
glutathione metabolic process  (IBA,IDA,ISO)
hepoxilin biosynthetic process  (ISO,ISS)
inflammatory response  (IDA)
linoleic acid metabolic process  (ISO)
negative regulation of acute inflammatory response  (NAS)
negative regulation of apoptotic process  (TAS)
negative regulation of biosynthetic process  (ISO)
negative regulation of canonical NF-kappaB signal transduction  (IDA)
negative regulation of ERK1 and ERK2 cascade  (IDA,ISO)
negative regulation of extrinsic apoptotic signaling pathway  (ISO,ISS)
negative regulation of fibroblast proliferation  (IMP)
negative regulation of interleukin-1 beta production  (IDA,ISO)
negative regulation of JNK cascade  (ISO)
negative regulation of JUN kinase activity  (ISO)
negative regulation of leukocyte proliferation  (IMP)
negative regulation of MAP kinase activity  (ISO)
negative regulation of monocyte chemotactic protein-1 production  (IDA,ISO)
negative regulation of neutrophil aggregation  (NAS)
negative regulation of protein kinase activity  (ISO)
negative regulation of smooth muscle cell chemotaxis  (ISO)
negative regulation of stress-activated MAPK cascade  (IDA)
negative regulation of tumor necrosis factor production  (IDA,ISO)
negative regulation of vascular associated smooth muscle cell proliferation  (ISO)
oligodendrocyte development  (ISO,ISS)
positive regulation of superoxide anion generation  (IMP)
prostaglandin metabolic process  (ISO,ISS)
regulation of ERK1 and ERK2 cascade  (IDA)
regulation of stress-activated MAPK cascade  (IDA)
response to amino acid  (ISO,ISS)
response to estradiol  (ISO,ISS)
response to ethanol  (ISO,ISS)
response to L-ascorbic acid  (ISO,ISS)
response to nutrient levels  (ISO,ISS)
response to reactive oxygen species  (IDA)
response to toxic substance  (ISO,ISS)
xenobiotic metabolic process  (ISO,ISS)

Cellular Component

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View

Mammalian Phenotype
References

References - curated
# Reference Title Reference Citation
1. Changes in tear protein profile in patients with conjunctivochalasis. Acera A, etal., Cornea. 2011 Jan;30(1):42-9. doi: 10.1097/ICO.0b013e3181dea7d7.
2. Glutathione S-transferase P1 Ile105Val polymorphism is associated with haematological toxicity in elderly rectal cancer patients receiving preoperative chemoradiotherapy. Agostini M, etal., Drugs Aging. 2008;25(6):531-9.
3. Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia. Allan JM, etal., Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11592-7. Epub 2001 Sep 11.
4. Effect of glutathione S-transferases on the survival of patients with acute myeloid leukaemia. Autrup JL, etal., Eur J Pharmacol. 2002 Mar 1;438(1-2):15-8.
5. The genetic association database. Becker KG, etal., Nat Genet. 2004 May;36(5):431-2.
6. Glutathione S-transferase P1 *C allelic variant increases susceptibility for late-onset Alzheimer disease: association study and relationship with apolipoprotein E epsilon4 allele. Bernardini S, etal., Clin Chem. 2005 Jun;51(6):944-51. Epub 2005 Apr 1.
7. Association of glutathione S-transferase (GSTM1, T1 and P1) gene polymorphisms with type 2 diabetes mellitus in north Indian population. Bid HK, etal., J Postgrad Med. 2010 Jul-Sep;56(3):176-81.
8. Influence of genetic factors on toluene diisocyanate-related symptoms: evidence from a cross-sectional study. Broberg K, etal., Environ Health. 2008 Apr 30;7:15.
9. Genetic polymorphisms associated with cigarette smoking and the risk of Graves' disease. Bufalo NE, etal., Clin Endocrinol (Oxf). 2008 Jun;68(6):982-7. Epub 2007 Nov 2.
10. Dietary chemoprevention of PhIP induced carcinogenesis in male Fischer 344 rats with tomato and broccoli. Canene-Adams K, etal., PLoS One. 2013 Nov 27;8(11):e79842. doi: 10.1371/journal.pone.0079842. eCollection 2013.
11. Maternal glutathione S-transferase GSTP1 genotype is a specific predictor of phenotype in children with asthma. Carroll WD, etal., Pediatr Allergy Immunol. 2005 Feb;16(1):32-9.
12. Polymorphisms of glutathione S-transferase genes and functional activity in smokers with or without COPD. Chan-Yeung M, etal., Int J Tuberc Lung Dis. 2007 May;11(5):508-14.
13. Proteomic profiling of brain cortex tissues in a Tau transgenic mouse model of Alzheimer's disease. Chang SH, etal., Biochem Biophys Res Commun. 2013 Jan 11;430(2):670-5. doi: 10.1016/j.bbrc.2012.11.093. Epub 2012 Dec 2.
14. Association of glutathione-S-transferase polymorphisms with atopic dermatitis risk in preschool age children. Chung J, etal., Clin Chem Lab Med. 2009;47(12):1475-81.
15. Polymorphism at the glutathione S-transferase P1 locus in Korean patients with perennial allergic rhinitis. Chung YS, etal., Am J Rhinol. 2006 Nov-Dec;20(6):648-51.
16. Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Cote ML, etal., Carcinogenesis. 2009 Apr;30(4):626-35. Epub 2009 Jan 27.
17. Normal bronchial epithelial cell expression of glutathione transferase P1, glutathione transferase M3, and glutathione peroxidase is low in subjects with bronchogenic carcinoma. Crawford EL, etal., Cancer Res. 2000 Mar 15;60(6):1609-18.
18. Correlation study on expression of GST-pi protein in brain tissue and peripheral blood of epilepsy rats induced by pilocarpine. Deng X, etal., J Huazhong Univ Sci Technolog Med Sci. 2011 Oct;31(5):701-4. doi: 10.1007/s11596-011-0586-x. Epub 2011 Oct 25.
19. Identification of glutathione S-transferase (GST) polymorphisms in brain tumors and association with susceptibility to pediatric astrocytomas. Ezer R, etal., J Neurooncol. 2002 Sep;59(2):123-34.
20. Glutathione S-transferases related to P. aeruginosa lung infection in cystic fibrosis children: preliminary study. Feuillet-Fieux MN, etal., Clin Biochem. 2009 Jan;42(1-2):57-63. Epub 2008 Oct 17.
21. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Fietta A, etal., Arthritis Res Ther. 2006;8(6):R160.
22. Polymorphism at the glutathione S-transferase GSTP1 locus. A new marker for bronchial hyperresponsiveness and asthma. Fryer AA, etal., Am J Respir Crit Care Med. 2000 May;161(5):1437-42.
23. Promoter methylation of glutathione S-transferase pi1 and multidrug resistance gene 1 in bronchioloalveolar carcinoma and its correlation with DNA methyltransferase 1 expression. Gao P, etal., Cancer. 2009 Jul 15;115(14):3222-32.
24. Association of glutathione S-transferase pi isoform single-nucleotide polymorphisms with exudative age-related macular degeneration in a Chinese population. Gu H, etal., Retina. 2012 Oct;32(9):1967-72.
25. A GSTP1 functional variant associated with cocaine dependence in a Brazilian population. Guindalini C, etal., Pharmacogenet Genomics. 2005 Dec;15(12):891-3. doi: 10.1097/01213011-200512000-00007.
26. Identification of genetic polymorphisms at the glutathione S-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Harries LW, etal., Carcinogenesis. 1997 Apr;18(4):641-4.
27. Suppressive effect of sulindac on branch duct-intraductal papillary mucinous neoplasms. Hayashi T, etal., J Gastroenterol. 2009;44(9):964-75. Epub 2009 Jun 18.
28. Liver disease in pediatric patients with cystic fibrosis is associated with glutathione S-transferase P1 polymorphism. Henrion-Caude A, etal., Hepatology. 2002 Oct;36(4 Pt 1):913-7.
29. The GSTP1 A1578G polymorphism and the risk of childhood acute lymphoblastic leukemia: results from an updated meta-analysis. Huang GZ, etal., Genet Mol Res. 2013 Jul 24;12(3):2481-91. doi: 10.4238/2013.July.24.3.
30. Protective effect of Jasonia montana against ethinylestradiol-induced cholestasis in rats. Hussein MA and Abdel-Gawad SM, Saudi Pharm J. 2010 Jan;18(1):27-33. doi: 10.1016/j.jsps.2009.12.002. Epub 2009 Dec 23.
31. Promoting Effects of Streptozotocin-induced Diabetes on Induction of Hepatic Preneoplastic Lesions by Diethylnitrosamine in Rats. Ichikawa K, etal., J Toxicol Pathol. 2010 Sep;23(3):125-31. doi: 10.1293/tox.23.125. Epub 2010 Oct 5.
32. Glutathione S-transferase genotype increases risk of progression from bronchial hyperresponsiveness to asthma in adults. Imboden M, etal., Thorax. 2008 Apr;63(4):322-8. Epub 2007 Dec 5.
33. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma. Jain S, etal., PLoS One. 2012;7(4):e35789. doi: 10.1371/journal.pone.0035789. Epub 2012 Apr 20.
34. Glutathione S-transferase gene polymorphisms and risk and survival of pancreatic cancer. Jiao L, etal., Cancer. 2007 Mar 1;109(5):840-8.
35. Polymorphic glutathione S-transferases as genetic risk factors for senile cortical cataract in Estonians. Juronen E, etal., Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2262-7.
36. Association study between glutathione S-transferase GST-M1, GST-T1, and GST-P1 polymorphisms and tardive dyskinesia. Kang SG, etal., Hum Psychopharmacol. 2009 Jan;24(1):55-60.
37. Common genotypic polymorphisms in glutathione S-transferases in mild and severe falciparum malaria in Tanzanian children. Kavishe RA, etal., Am J Trop Med Hyg. 2009 Aug;81(2):363-5.
38. Genetic polymorphism of metabolic enzymes modifies the risk of chronic solvent-induced encephalopathy. Kezic S, etal., Toxicol Ind Health. 2006 Aug;22(7):281-9.
39. Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients. Khrunin AV, etal., Pharmacogenomics J. 2010 Feb;10(1):54-61. Epub 2009 Sep 29.
40. Genetic polymorphisms in glutathione S-transferases and cytochrome P450s, tobacco smoking, and risk of non-Hodgkin lymphoma. Kilfoy BA, etal., Am J Hematol. 2009 May;84(5):279-82. doi: 10.1002/ajh.21386.
41. Association of COPD candidate genes with CT emphysema and airway phenotypes in severe COPD. Kim WJ, etal., Eur Respir J. 2010 Jun 4.
42. Non-alcoholic steatohepatitis and preneoplastic lesions develop in the liver of obese and hypertensive rats: suppressing effects of EGCG on the development of liver lesions. Kochi T, etal., Cancer Lett. 2014 Jan 1;342(1):60-9. doi: 10.1016/j.canlet.2013.08.031. Epub 2013 Aug 24.
43. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Koyner JL, etal., Clin J Am Soc Nephrol. 2010 Dec;5(12):2154-65. Epub 2010 Aug 26.
44. Relationship between glutathione S-transferase P1 polymorphisms and chronic obstructive pulmonary disease in a Tunisian population. Lakhdar R, etal., Genet Mol Res. 2010 May 11;9(2):897-907.
45. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. Leonard MO, etal., FASEB J. 2006 Dec;20(14):2624-6.
46. A Three-Way Interaction among Maternal and Fetal Variants Contributing to Congenital Heart Defects. Li M, etal., Ann Hum Genet. 2016 Jan;80(1):20-31. doi: 10.1111/ahg.12139. Epub 2015 Nov 27.
47. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes. Longuemaux S, etal., Cancer Res. 1999 Jun 15;59(12):2903-8.
48. Recombinant protein glutathione S-transferases P1 attenuates inflammation in mice. Luo L, etal., Mol Immunol. 2009 Feb;46(5):848-57. Epub 2008 Oct 28.
49. Response to chemotherapy and tandem autologous transplantation of multiple myeloma patients and GSTP1 and TYMS polymorphisms. Maggini V, etal., Leuk Res. 2008 Jan;32(1):49-53. Epub 2007 May 23.
50. Lack of association of NQO1 and GSTP1 polymorphisms with multiple myeloma risk. Maggini V, etal., Leuk Res. 2008 Jun;32(6):988-90. Epub 2007 Dec 3.
51. Association of glutathione-S-transferase-P1 (GST-P1) polymorphisms with bronchopulmonary dysplasia. Manar MH, etal., J Perinatol. 2004 Jan;24(1):30-5.
52. Glutathione S-transferase polymorphisms in MS: their relationship to disability. Mann CL, etal., Neurology. 2000 Feb 8;54(3):552-7.
53. Polymorphisms in the glutathione pathway modulate cystic fibrosis severity: a cross-sectional study. Marson FA, etal., BMC Med Genet. 2014 Mar 4;15:27. doi: 10.1186/1471-2350-15-27.
54. Interactions between glutathione S-transferase P1, tumor necrosis factor, and traffic-related air pollution for development of childhood allergic disease. Melen E, etal., Environ Health Perspect. 2008 Aug;116(8):1077-84.
55. Parkinson's disease, pesticides, and glutathione transferase polymorphisms. Menegon A, etal., Lancet 1998 Oct 24;352(9137):1344-6.
56. Relationship between GSTP1 Ile(105)Val polymorphism and docetaxel-induced peripheral neuropathy: clinical evidence of a role of oxidative stress in taxane toxicity. Mir O, etal., Ann Oncol. 2009 Apr;20(4):736-40. Epub 2009 Feb 17.
57. Glycine soya diet synergistically enhances the suppressive effect of tamoxifen and inhibits tamoxifen-promoted hepatocarcinogenesis in 7,12-dimethylbenzanthracene-induced rat mammary tumor model. Mishra R, etal., Food Chem Toxicol. 2011 Feb;49(2):434-40. doi: 10.1016/j.fct.2010.11.020. Epub 2010 Nov 17.
58. Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester. Nakajima T, etal., J Pharmacol Exp Ther. 2003 Sep;306(3):861-9. doi: 10.1124/jpet.103.052696. Epub 2003 Jun 12.
59. The Interaction between GSTT1, GSTM1, and GSTP1 Ile105Val Gene Polymorphisms and Environmental Risk Factors in Premalignant Gastric Lesions Risk. Negovan A, etal., Biomed Res Int. 2017;2017:7365080. doi: 10.1155/2017/7365080. Epub 2017 Jan 15.
60. Association study of Glutathione S-transferase P1 (GSTP1) with asthma and bronchial hyper-responsiveness in two German pediatric populations. Nickel R, etal., Pediatr Allergy Immunol. 2005 Sep;16(6):539-41.
61. Polymorphisms in xenobiotic metabolizing enzymes and diet influence colorectal adenoma risk. Northwood EL, etal., Pharmacogenet Genomics. 2010 May;20(5):315-26. doi: 10.1097/FPC.0b013e3283395c6a.
62. Assessment of the XPC (A2920C), XPF (T30028C), TP53 (Arg72Pro) and GSTP1 (Ile105Val) polymorphisms in the risk of cutaneous melanoma. Oliveira C, etal., J Cancer Res Clin Oncol. 2013 Jul;139(7):1199-206. doi: 10.1007/s00432-013-1430-4. Epub 2013 Apr 9.
63. Evaluation of polymorphisms in repair and detoxification genes in alcohol drinkers and non-drinkers using capillary electrophoresis. Oliveira de Araújo Melo C, etal., Electrophoresis. 2020 Feb;41(3-4):254-258. doi: 10.1002/elps.201900193. Epub 2020 Jan 20.
64. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. Oyama K, etal., Carcinogenesis. 2002 May;23(5):885-92.
65. Glutathione s-transferase m1, t1, and p1 gene polymorphism in exudative age-related macular degeneration: a preliminary report. Oz O, etal., Eur J Ophthalmol. 2006 Jan - Feb;16(1):105-110. doi: 10.5301/EJO.2008.3524.
66. Glutathione S-transferase M1, T1, and P1 gene polymorphism in exudative age-related macular degeneration: a preliminary report. Oz O, etal., Eur J Ophthalmol. 2006 Jan-Feb;16(1):105-10.
67. Interaction between early maternal smoking and variants in TNF and GSTP1 in childhood wheezing. Panasevich S, etal., Clin Exp Allergy. 2010 Mar;40(3):458-67.
68. Genetic polymorphisms in GSTM1, GSTT1, GSTP1, GSTM3 and the susceptibility to gallbladder cancer in North India. Pandey SN, etal., Biomarkers. 2006 May-Jun;11(3):250-61.
69. DNA methylation of multiple tumor-related genes in association with overexpression of DNA methyltransferase 1 (DNMT1) during multistage carcinogenesis of the pancreas. Peng DF, etal., Carcinogenesis. 2006 Jun;27(6):1160-8. Epub 2006 Mar 14.
70. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
71. SMPDB Annotation Import Pipeline Pipeline to import SMPDB annotations from SMPDB into RGD
72. Polymorphisms in glutathione S-transferases are associated with altered risk of nonmelanoma skin cancer in renal transplant recipients: a preliminary analysis. Ramsay HM, etal., J Invest Dermatol. 2001 Aug;117(2):251-5.
73. GSTM1, GSTP1, and NQO1 polymorphisms and susceptibility to atopy and airway hyperresponsiveness among South African schoolchildren. Reddy P, etal., Lung. 2010 Oct;188(5):409-14. Epub 2010 Jun 5.
74. Characterization of 4-hydroxy-2-nonenal metabolism in stellate cell lines derived from normal and cirrhotic rat liver. Reichard JF, etal., Biochim Biophys Acta. 2000 Sep 27;1487(2-3):222-32.
75. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
76. Polymorphisms of GSTP1 and GSTT1, but not of CYP2A6, CYP2E1 or GSTM1, modify the risk for esophageal cancer in a western population. Rossini A, etal., Carcinogenesis. 2007 Dec;28(12):2537-42. doi: 10.1093/carcin/bgm222. Epub 2007 Oct 4.
77. Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism. Rybicki BA, etal., Cancer Detect Prev. 2006;30(5):412-22. Epub 2006 Oct 25.
78. Proteomic analysis of psoriatic skin tissue for identification of differentially expressed proteins: Up-regulation of GSTP1, SFN and PRDX2 in psoriatic skin. Ryu J, etal., Int J Mol Med. 2011 Nov;28(5):785-92. doi: 10.3892/ijmm.2011.757. Epub 2011 Jul 25.
79. Association of the GSTP1 gene (Ile105Val) polymorphism with chronic myeloid leukemia. Sailaja K, etal., Asian Pac J Cancer Prev. 2010;11(2):461-4.
80. Protective effect of gamma-tocopherol-enriched diet on N-methyl-N-nitrosourea-induced epithelial dysplasia in rat ventral prostate. Sanches LD, etal., Int J Exp Pathol. 2013 Dec;94(6):362-72. doi: 10.1111/iep.12042. Epub 2013 Oct 29.
81. The role of GSTP1 polymorphisms and tobacco smoke exposure in children with acute asthma. Schultz EN, etal., J Asthma. 2010 Nov;47(9):1049-56.
82. Polymorphism in Cytochrome P450 2D6, Glutathione S-Transferases Pi 1 Genes, and Organochlorine Pesticides in Alzheimer Disease: A Case-Control Study in North Indian Population. Singh NK, etal., J Geriatr Psychiatry Neurol. 2014 Feb 28;27(2):119-127.
83. Glutathione S-transferase P1 and T1 gene polymorphisms predict longitudinal course and age at onset of Alzheimer disease. Spalletta G, etal., Am J Geriatr Psychiatry. 2007 Oct;15(10):879-87.
84. Polymorphisms at the glutathione S-transferase, GSTP1 locus: a novel mechanism for susceptibility and development of atopic airway inflammation. Spiteri MA, etal., Allergy. 2000;55 Suppl 61:15-20.
85. Polymorphisms within glutathione S-transferase genes (GSTM1, GSTT1, GSTP1) and risk of relapse in childhood B-cell precursor acute lymphoblastic leukemia: a case-control study. Stanulla M, etal., Blood. 2000 Feb 15;95(4):1222-8.
86. Glutathione S-transferase P1 mRNA expression in plasma cell disorders and its correlation with polymorphic variants and clinical outcome. Stella F, etal., Cancer Epidemiol. 2013 Oct;37(5):671-4. doi: 10.1016/j.canep.2013.07.004. Epub 2013 Aug 14.
87. Changes in polypeptide pattern of rat liver cells during chemical hepatocarcinogenesis. Sugioka Y, etal., Cancer Res. 1985 Jan;45(1):365-78.
88. Pharmacogenetic association between GSTP1 genetic polymorphism and febrile neutropenia in Japanese patients with early breast cancer. Sugishita M, etal., Breast Cancer. 2014 Jul 10.
89. Proteomic analysis of clear cell renal cell carcinoma. Identification of potential tumor markers. Sun CY, etal., Saudi Med J. 2010 May;31(5):525-32.
90. Possible involvement of genotoxic mechanisms in estragole-induced hepatocarcinogenesis in rats. Suzuki Y, etal., Arch Toxicol. 2012 Oct;86(10):1593-601. doi: 10.1007/s00204-012-0865-8. Epub 2012 May 11.
91. Decreased expression of antioxidant enzymes and increased expression of chemokines in COPD lung. Tomaki M, etal., Pulm Pharmacol Ther. 2007;20(5):596-605. Epub 2006 Jul 11.
92. Increased expression of alpha-1-antitrypsin, glutathione S-transferase pi and vascular endothelial growth factor in human pancreatic adenocarcinoma. Trachte AL, etal., Am J Surg. 2002 Dec;184(6):642-7; discussion 647-8.
93. Young patients with oral squamous cell carcinoma: study of the involvement of GSTP1 and deregulation of the Fanconi anemia genes. Tremblay S, etal., Arch Otolaryngol Head Neck Surg. 2006 Sep;132(9):958-66.
94. Pharmacogenetic influence of GST polymorphisms on anthracycline-based chemotherapy responses and toxicity in breast cancer patients: a multi-analytical approach. Tulsyan S, etal., Mol Diagn Ther. 2013 Dec;17(6):371-9. doi: 10.1007/s40291-013-0045-4.
95. Genetic polymorphisms of GSTP1 and mEPHX correlate with oxidative stress markers and lung function in COPD. Vibhuti A, etal., Biochem Biophys Res Commun. 2007 Jul 20;359(1):136-42. Epub 2007 May 22.
96. Association of A313 G polymorphism (GSTP1*B) in the glutathione-S-transferase P1 gene with sporadic Parkinson's disease. Vilar R, etal., Eur J Neurol. 2007 Feb;14(2):156-61.
97. The association between glutathione S-transferase gene polymorphisms and pancreatic cancer in a central European Slavonic population. Vrana D, etal., Mutat Res. 2009 Nov-Dec;680(1-2):78-81. Epub 2009 Sep 26.
98. GSTM1, GSTP1, prenatal smoke exposure, and atopic dermatitis. Wang IJ, etal., Ann Allergy Asthma Immunol. 2010 Aug;105(2):124-9. Epub 2010 Jun 11.
99. Effects of arsenic exposure and genetic polymorphisms of p53, glutathione S-transferase M1, T1, and P1 on the risk of carotid atherosclerosis in Taiwan. Wang YH, etal., Atherosclerosis. 2007 Jun;192(2):305-12. Epub 2006 Sep 14.
100. Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion. Watanabe T, etal., Stroke. 2006 Jun;37(6):1539-45. Epub 2006 Apr 27.
101. In utero smoke exposure, glutathione S-transferase P1 haplotypes, and respiratory illness-related absence among schoolchildren. Wenten M, etal., Pediatrics. 2009 May;123(5):1344-51.
102. Association analysis of drug metabolizing enzyme gene polymorphisms in AIDS patients with cutaneous reactions to sulfonamides. Wolkenstein P, etal., J Invest Dermatol. 2005 Nov;125(5):1080-2.
103. Glutathione-S-transferase variants and adult glioma. Wrensch M, etal., Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):461-7.
104. The presence and significance of the Pi class glutathione S-transferase isoenzyme in cerebrospinal fluid during the course of meningitis in children. Wylie-Modro S, etal., Pediatr Res. 1997 Aug;42(2):232-6.
105. [Relation of GSTP1 and CYP2E1 polymorphisms with susceptibility to acute leukemia]. Xi YM, etal., Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2011 Jun;19(3):589-93.
106. Promoter methylation profiles of tumor suppressor genes in intrahepatic and extrahepatic cholangiocarcinoma. Yang B, etal., Mod Pathol. 2005 Mar;18(3):412-20.
107. Vascular tight junction disruption and angiogenesis in spontaneously hypertensive rat with neuroinflammatory white matter injury. Yang Y, etal., Neurobiol Dis. 2018 Jun;114:95-110. doi: 10.1016/j.nbd.2018.02.012. Epub 2018 Feb 24.
108. Association analysis of glutathione-S-transferase P1 (GSTP1) polymorphism with urothelial cancer susceptibility and myelosuppression after M-VAC chemotherapy. Yokomizo A, etal., Int J Urol. 2007 Jun;14(6):500-4.
109. Genetic determinants in the metabolism of bladder carcinogens in relation to risk of bladder cancer. Yuan JM, etal., Carcinogenesis. 2008 Jul;29(7):1386-93. Epub 2008 Jun 9.
110. Relationship between glutathione S-transferase M1, T1, and P1 polymorphisms and chronic lymphocytic leukemia. Yuille M, etal., Blood. 2002 Jun 1;99(11):4216-8.
111. Association of A(313)G glutathione S-transferase P1 germline polymorphism with susceptibility to de novo myelodysplastic syndrome. Zachaki S, etal., Leuk Lymphoma. 2013 Aug;54(8):1756-61. doi: 10.3109/10428194.2012.762647. Epub 2013 Jan 28.
112. Inhibition of urinary bladder carcinogenesis by aqueous extract of sclerotia of Polyporus umbellatus fries and polyporus polysaccharide. Zhang G, etal., Am J Chin Med. 2011;39(1):135-44.
113. Relationship of glutathione S-transferase genotypes with side-effects of pulsed cyclophosphamide therapy in patients with systemic lupus erythematosus. Zhong S, etal., Br J Clin Pharmacol. 2006 Oct;62(4):457-72.
114. Glutathione transferase P1: an endogenous inhibitor of allergic responses in a mouse model of asthma. Zhou J, etal., Am J Respir Crit Care Med. 2008 Dec 15;178(12):1202-10. Epub 2008 Sep 11.
115. [Identification of tumor-associated proteins in laryngeal squamous cell carcinoma by proteomics] Zhou JR, etal., Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2007 Dec;42(12):934-8.
116. A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small cell lung cancer in smokers. Zienolddiny S, etal., Carcinogenesis. 2008 Jun;29(6):1164-9. Epub 2008 Feb 6.
117. [Increased frequency of A-G transition at exon 5 of GSTP1 as a genetic risk factor for acute childhood leukaemia]. Zubowska M, etal., Med Wieku Rozwoj. 2004 Apr-Jun;8(2 Pt 1):245-57.
118. Paternal contribution to the risk for pre-eclampsia. Zusterzeel PL, etal., J Med Genet 2002 Jan;39(1):44-5.
Additional References at PubMed
PMID:2388840   PMID:7982937   PMID:8135745   PMID:8145243   PMID:8584275   PMID:8605288   PMID:9446594   PMID:9511175   PMID:9560266   PMID:9730611   PMID:10349636   PMID:10922068  
PMID:10945608   PMID:11042159   PMID:11058152   PMID:11076861   PMID:11217851   PMID:11279197   PMID:11408560   PMID:11433346   PMID:12023900   PMID:12225863   PMID:12466851   PMID:12477932  
PMID:12646564   PMID:14517554   PMID:14610273   PMID:14681479   PMID:14684749   PMID:15100242   PMID:15386426   PMID:15489334   PMID:16023107   PMID:16141072   PMID:16141073   PMID:16160063  
PMID:16374777   PMID:16399382   PMID:16602821   PMID:17267597   PMID:17909032   PMID:18268004   PMID:18349876   PMID:18792812   PMID:18799693   PMID:18990698   PMID:19269317   PMID:19270193  
PMID:19718438   PMID:19739253   PMID:19915149   PMID:19935654   PMID:20404090   PMID:20538586   PMID:21134126   PMID:21267068   PMID:21748757   PMID:21873635   PMID:21975931   PMID:22022436  
PMID:22084240   PMID:22496890   PMID:22627280   PMID:22751926   PMID:22828627   PMID:22956844   PMID:23129554   PMID:23164639   PMID:23237955   PMID:23647087   PMID:24457600   PMID:24664677  
PMID:25216273   PMID:25590808   PMID:25868843   PMID:25891661   PMID:26169370   PMID:26361746   PMID:26838680   PMID:27058114   PMID:27086966   PMID:27160897   PMID:29348462   PMID:29374060  
PMID:29382714   PMID:29520271   PMID:29732603   PMID:30153066   PMID:30290218   PMID:30457570   PMID:30595499   PMID:31299423   PMID:31515511   PMID:32320793   PMID:32325033   PMID:32719131  
PMID:33437989   PMID:34624602   PMID:36114006   PMID:36293380   PMID:36577249   PMID:37072933   PMID:37142655   PMID:37677999   PMID:38062045   PMID:38169591   PMID:38355793   PMID:38479222  


Genomics

Comparative Map Data
Gstp1
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39194,085,411 - 4,087,912 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl194,085,407 - 4,087,985 (-)EnsemblGRCm39 Ensembl
GRCm38194,035,411 - 4,037,912 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl194,035,407 - 4,037,985 (-)EnsemblGRCm38mm10GRCm38
MGSCv37194,035,411 - 4,037,912 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv36194,035,411 - 4,037,912 (-)NCBIMGSCv36mm8
Celera193,906,327 - 3,908,828 (-)NCBICelera
Cytogenetic Map19ANCBI
cM Map193.75NCBI
GSTP1
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh381167,583,812 - 67,586,653 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl1167,583,742 - 67,586,656 (+)EnsemblGRCh38hg38GRCh38
GRCh371167,351,283 - 67,354,124 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 361167,107,862 - 67,110,699 (+)NCBINCBI36Build 36hg18NCBI36
Build 341167,107,861 - 67,110,699NCBI
Celera1164,685,527 - 64,688,585 (+)NCBICelera
Cytogenetic Map11q13.2NCBI
HuRef1163,680,236 - 63,683,230 (+)NCBIHuRef
CHM1_11167,234,118 - 67,237,177 (+)NCBICHM1_1
T2T-CHM13v2.01167,578,501 - 67,581,343 (+)NCBIT2T-CHM13v2.0
Gstp1
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr81210,767,237 - 210,770,242 (-)NCBIGRCr8
mRatBN7.21201,337,762 - 201,340,230 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl1201,321,672 - 201,340,226 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx1209,690,040 - 209,692,503 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.01216,783,226 - 216,785,696 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.01209,474,253 - 209,476,723 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.01219,291,679 - 219,294,147 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl1219,291,679 - 219,294,147 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.01226,162,330 - 226,164,798 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.41206,627,398 - 206,629,866 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.11206,780,853 - 206,783,288 (-)NCBI
Celera1198,882,807 - 198,885,275 (-)NCBICelera
Cytogenetic Map1q43NCBI
Gstp1
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495542217,914,305 - 17,917,428 (-)EnsemblChiLan1.0
ChiLan1.0NW_00495542217,914,228 - 17,916,918 (-)NCBIChiLan1.0ChiLan1.0
GSTP1
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v2968,811,099 - 68,814,237 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11169,853,927 - 69,856,897 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v01162,942,756 - 62,945,701 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.11166,253,421 - 66,256,472 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl1166,253,421 - 66,256,472 (+)Ensemblpanpan1.1panPan2
GSTP1
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.11849,905,161 - 49,908,182 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1849,905,161 - 49,908,182 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha1848,515,700 - 48,518,722 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.01850,827,487 - 50,830,507 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl1850,827,046 - 50,830,507 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.11850,040,622 - 50,043,638 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01849,615,622 - 49,618,639 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01850,409,350 - 50,412,373 (-)NCBIUU_Cfam_GSD_1.0
Gstp1
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_0244049475,755,332 - 5,758,293 (-)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_0049365992,197,634 - 2,201,050 (-)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_0049365992,197,681 - 2,200,642 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
LOC100739163
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.124,978,761 - 4,982,233 (-)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.223,618,596 - 3,620,933 (-)NCBISscrofa10.2Sscrofa10.2susScr3
GSTP1
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.116,676,897 - 6,679,936 (-)NCBIChlSab1.1ChlSab1.1chlSab2
Vero_WHO_p1.0NW_023666038103,955,106 - 103,991,379 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0

miRNA Target Status (No longer updated)

Predicted Target Of
Summary Value
Count of predictions:161
Count of miRNA genes:159
Interacting mature miRNAs:161
Transcripts:ENSMUST00000169613
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


QTLs in Region (GRCm39)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
4142302Nstr1_mnerve sheath tumor resistance QTL 1 (mouse)Not determined19122371338Mouse
1301271Datd_mdopamine transporter density (mouse)Not determined19132340234Mouse
1300923Bits4_mbitterness sensitivity 4 (mouse)Not determined19332321637323348Mouse
4142406Pbctlp1_mperipheral blood cytotoxic T lymphocyte percentage 1 (mouse)Not determined132875174Mouse
1300776Lfp3_mlong free running period 3 (mouse)Not determined19120328703Mouse
1300904Chab5_mcholesterol absorption 5 (mouse)Not determined19165376435653927Mouse
26884385Skwq14_mskull length QTL 14, 16 week (mouse)19325000035877400Mouse
1301800Faq10_mfluctuating asymmetry QTL 10 (mouse)Not determined19332321637323348Mouse
1300591Pas3_mpulmonary adenoma susceptibility 3 (mouse)Not determined19332321637323348Mouse
1302126Skull26_mskull morphology 26 (mouse)Not determined19332321637323348Mouse
4142161Drinksac2_mdrink saccharin 2 (mouse)Not determined120695286Mouse
1357819Tgct2_mtesticular germ cell tumor 2 (mouse)Not determined19332855120539663Mouse


Expression

RNA-SEQ Expression


Sequence


Ensembl Acc Id: ENSMUST00000169613   ⟹   ENSMUSP00000129565
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,085,407 - 4,087,985 (-)Ensembl
GRCm38.p6 Ensembl194,035,407 - 4,037,985 (-)Ensembl
Ensembl Acc Id: ENSMUST00000235711
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,087,071 - 4,087,877 (-)Ensembl
GRCm38.p6 Ensembl194,037,071 - 4,037,877 (-)Ensembl
Ensembl Acc Id: ENSMUST00000236211
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,085,409 - 4,085,993 (-)Ensembl
GRCm38.p6 Ensembl194,035,409 - 4,035,993 (-)Ensembl
Ensembl Acc Id: ENSMUST00000236311
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,085,414 - 4,086,382 (-)Ensembl
GRCm38.p6 Ensembl194,035,414 - 4,036,382 (-)Ensembl
Ensembl Acc Id: ENSMUST00000237239
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,085,827 - 4,087,901 (-)Ensembl
GRCm38.p6 Ensembl194,035,827 - 4,037,901 (-)Ensembl
Ensembl Acc Id: ENSMUST00000237273
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,086,767 - 4,087,896 (-)Ensembl
GRCm38.p6 Ensembl194,036,767 - 4,037,896 (-)Ensembl
Ensembl Acc Id: ENSMUST00000237773
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,087,315 - 4,087,899 (-)Ensembl
GRCm38.p6 Ensembl194,037,315 - 4,037,899 (-)Ensembl
Ensembl Acc Id: ENSMUST00000237893   ⟹   ENSMUSP00000158260
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,085,411 - 4,087,977 (-)Ensembl
GRCm38.p6 Ensembl194,035,411 - 4,037,977 (-)Ensembl
Ensembl Acc Id: ENSMUST00000237982   ⟹   ENSMUSP00000157438
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39 Ensembl194,085,573 - 4,087,925 (-)Ensembl
GRCm38.p6 Ensembl194,035,573 - 4,037,925 (-)Ensembl
RefSeq Acc Id: NM_013541   ⟹   NP_038569
RefSeq Status: VALIDATED
Type: CODING
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm39194,085,411 - 4,087,912 (-)NCBI
GRCm38194,035,411 - 4,037,912 (-)ENTREZGENE
MGSCv37194,035,411 - 4,037,912 (-)RGD
Celera193,906,327 - 3,908,828 (-)RGD
cM Map19 ENTREZGENE
Sequence:
RefSeq Acc Id: NP_038569   ⟸   NM_013541
- UniProtKB: Q8BNY4 (UniProtKB/Swiss-Prot),   P19157 (UniProtKB/Swiss-Prot),   A0A494BAW2 (UniProtKB/TrEMBL)
- Sequence:
Ensembl Acc Id: ENSMUSP00000157438   ⟸   ENSMUST00000237982
Ensembl Acc Id: ENSMUSP00000158260   ⟸   ENSMUST00000237893
Ensembl Acc Id: ENSMUSP00000129565   ⟸   ENSMUST00000169613
Protein Domains
GST C-terminal   GST N-terminal

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P19157-F1-model_v2 AlphaFold P19157 1-210 view protein structure

Promoters
RGD ID:6830115
Promoter ID:MM_KWN:25965
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:3T3L1_Day0,   3T3L1_Day1,   3T3L1_Day2,   3T3L1_Day3,   3T3L1_Day4,   3T3L1_Day6,   BoneMarrow_0Hour,   BoneMarrow_2Hour,   BoneMarrow_4Hour,   Brain,   ES_Cell,   Kidney,   Liver,   Lung,   MEF_B4,   MEF_B6,   Spleen
Transcripts:ENSMUST00000042898
Position:
Mouse AssemblyChrPosition (strand)Source
MGSCv36194,037,536 - 4,038,036 (-)MPROMDB
RGD ID:13678374
Promoter ID:EPDNEW_M23337
Type:initiation region
Name:Gstp1_1
Description:Mus musculus glutathione S-transferase, pi 1 , mRNA.
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Mouse AssemblyChrPosition (strand)Source
GRCm38194,037,925 - 4,037,985EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene MGI:95865 AgrOrtholog
Ensembl Genes ENSMUSG00000060803 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Transcript ENSMUST00000169613 ENTREZGENE
  ENSMUST00000169613.4 UniProtKB/Swiss-Prot
  ENSMUST00000237893.2 UniProtKB/TrEMBL
  ENSMUST00000237982.2 UniProtKB/TrEMBL
Gene3D-CATH 1.20.1050.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Glutaredoxin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro Glutathione-S-Trfase_C-like UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Glutathione-S-Trfase_C_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Glutathione_S-Trfase UniProtKB/TrEMBL
  Glutathione_S-Trfase_N UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  GST_C UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  GST_pi UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  GST_superfamily UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Thioredoxin-like_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report mmu:14870 UniProtKB/Swiss-Prot
MGD MGI:95865 ENTREZGENE
NCBI Gene 14870 ENTREZGENE
PANTHER GLUTATHIONE S-TRANSFERASE UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  GLUTATHIONE S-TRANSFERASE P UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam GST_C UniProtKB/TrEMBL
  GST_C_3 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  GST_N UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB GSTP1 RGD
PhenoGen Gstp1 PhenoGen
PRINTS GSTRNSFRASEP UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PROSITE GST_CTER UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  GST_NTER UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP SSF47616 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  SSF52833 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt A0A494B908_MOUSE UniProtKB/TrEMBL
  A0A494BAW2 ENTREZGENE, UniProtKB/TrEMBL
  GSTP1_MOUSE UniProtKB/Swiss-Prot, ENTREZGENE
  Q8BNY4 ENTREZGENE
UniProt Secondary Q8BNY4 UniProtKB/Swiss-Prot